The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world comparison of cabazitaxel vs. 177-lutetium-PSMA radioligand therapy in metastatic castration resistant prostate cancer.
 
Mike Wenzel
Honoraria - Accord Healthcare; AstraZeneca; Ipsen; Johnsen&Johnsen; MSD; MSD; Pfizer
 
Florestan Koll
No Relationships to Disclose
 
Benedikt Hoeh
No Relationships to Disclose
 
Clara Humke
No Relationships to Disclose
 
Carolin Siech
No Relationships to Disclose
 
Nicolai Mader
No Relationships to Disclose
 
Daniel Groener
Honoraria - Sanofi Aventis GmbH
 
Thomas Steuber
Honoraria - Astellas Pharma; Bayer; J&J; Novartis
Consulting or Advisory Role - Astellas Pharma; Johnson & Johnson/MedTech
 
Markus Graefen
Honoraria - Astellas Pharma; Bayer; Janssen; Medtronic; Takeda
Consulting or Advisory Role - Medtronic
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Janssen; Takeda
 
Tobias Maurer
No Relationships to Disclose
 
Christian Brandts
No Relationships to Disclose
 
Severine Banek
No Relationships to Disclose
 
Felix Chun
No Relationships to Disclose
 
Philipp Mandel
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Ipsen; Johnson & Johnson/Janssen; MSD; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Janssen Oncology; Novartis
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; Johnson & Johnson/Janssen; Novartis